DOI: 10.1001/jamahealthforum.2026.3983 ISSN: 2689-0186

Savings Across Drugs Under the GENEROUS Model in the US Medicaid Program

Jeromie Ballreich, Nathan Jibat, Tucker Desmond, Joseph Levy

This economic evaluation examines which drugs and therapeutic classes contribute to the most savings in the Generating Cost Reductions for US Medicaid model inclusive of statutory and supplemental rebates.

More from our Archive